3 citations
,
August 2020 in “Journal of The American Academy of Dermatology”
This study observed that patients with scalpdysesthesia frequently exhibited cervical spine degenerative changes, which localized predominantly in the lower cervical spine, and reported modest symptom improvement with neuropathic pain medications and physical therapy.
This review discusses potential mechanisms and treatments for trichodynia, noting a lack of strong literature support and reporting no new clinical results; the authors highlight several hypotheses and available treatment options.
This study identifies a specific subtype of Telogen Effluvium associated with scalpdysesthesia, such as itch or burning, in the absence of any inflammatory scalp disorder or medication association.
A 23-year-old male experiencing worsening hair loss has tried topical Minoxidil, Finasteride, Progesterone, Hydrocortisone butyrate, and Ketoconazole. He is considering switching to oral Finasteride due to concerns about side effects and lack of improvement.